🇺🇸 FDA
Pipeline program

UNEX-42

UNX-BP-101

Phase 1 mab terminated

Quick answer

UNEX-42 for Bronchopulmonary Dysplasia is a Phase 1 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Bronchopulmonary Dysplasia
Phase
Phase 1
Modality
mab
Status
terminated

Clinical trials